EV/EBITDA
-1.51
-0.02-1.34%
43 min ago
Summary
- As of March 10, 2025, ACRV EV/EBITDA is -1.51, with a fall of -0.02 (-1.34%) during the most recent trading day.
- Over the past year, ACRV EV/EBITDA has dropped by -0.22 (-17.05%).
- ACRV EV/EBITDA is now -122.06% below its all-time high of -0.68.
Performance
ACRV EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ACRV EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.3% | +1.2% | +0.9% |
| 1 m1 month | +9.0% | -9.1% | -7.1% |
| 3 m3 months | +28.1% | -28.1% | -23.0% |
| 6 m6 months | +49.7% | -43.8% | -38.2% |
| ytdytd | +13.7% | -13.9% | -11.0% |
| 1 y1 year | -17.1% | +41.7% | +9.6% |
| 5 y5 years | - | - | - |
ACRV EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -9.4% | -1.76 | +14.2% | |
| 3 m | 3-month | -1.38 | -9.4% | -2.19 | +31.1% |
| 6 m | 6-month | -1.38 | -9.4% | -3.53 | +57.2% |
| 1 y | 1-year | -1.23 | -22.8% | -4.51 | +66.5% |
| 3 y | 3-year | -0.68 | -122.1% | -14.99 | +89.9% |
| 5 y | 5-year | -0.68 | -122.1% | -14.99 | +89.9% |
| alltime | all time | -0.68 | -122.1% | -14.99 | +89.9% |
Acrivon Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.51(-13.7%) |
| 2024 | -1.75(+47.1%) |
| Date | Value |
|---|---|
| 2023 | -1.19(-83.1%) |
| 2022 | -7.06 |
FAQ
- What is Acrivon Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Acrivon Therapeutics?
- What is ACRV EV/EBITDA year-to-date change?
- What is Acrivon Therapeutics EV/EBITDA year-on-year change?
What is Acrivon Therapeutics EV/EBITDA?
The current EV/EBITDA of ACRV is -1.51
What is the all time high EV/EBITDA for Acrivon Therapeutics?
Acrivon Therapeutics all-time high EV/EBITDA is -0.68
What is ACRV EV/EBITDA year-to-date change?
Acrivon Therapeutics EV/EBITDA has changed by +0.24 (+13.71%) since the beginning of the year
What is Acrivon Therapeutics EV/EBITDA year-on-year change?
Over the past year, ACRV EV/EBITDA has changed by -0.22 (-17.05%)